|
Why
Isn’t the H1N1 Pandemic Flu Being Investigated as a Designed Bioweapon?
by
Bill Sardi
Recently
by Bill Sardi: Flu
Season Has Peaked; Vaccination Would Only Reduce Number of Infected
Americans By 6 Percent; Young Children Would Receive No Benefit
Strange as
it may seem, in an era of heightened concern about biological terrorism,
there appears to be little or no talk about the triple-reassortant
H1N1 pandemic flu virus as a laboratory-designed bioweapon.
Certainly,
this is not out of the question technologically. It is now
entirely possible for scientists to artificially re-create an infectious
agent from scratch. Researchers have demonstrated that a polio virus
can be reduced to a chemical, C332,652H492,388N98,245O131,196-P7501S2340,
and assembled by following its written genetic code. (Viruses
are not live organisms, they are sequences of genes that must rely
upon entry into a host cell nucleus to utilize the cell’s genetic
mechanisms for reproduction.) When a synthetically-created polio
virus was introduced into the spinal cords of mice it created the
same paralysis seen in polio.1
The synthesis
of flu viruses became more than a possibility in 1999 when researchers
demonstrated it was possible to overcome the previously insurmountable
problem of arranging eight segments of RNA. This was accomplished
by generation of RNA using an enzyme, RNA polymerase, essentially
creating a cloned flu virus.2
Fear spreads
faster than the flu
Certainly imagined
rather than factually-based fear is at the core of concern over
this H1N1 pandemic flu outbreak. Tuberculosis, another infectious
disease, globally kills nearly 2 million every year, compared to
250,000–500,000 from the flu, but a $9 billion effort to eradicate
it is not mounted against TB as has occurred with the 2009 "swine
flu."
The lateflu
season introduction of the pandemic, starting in Mexico in March
of 2009, creates a similar frightening scenario to the 1918 Spanish
flu outbreak that killed millions worldwide. If an engineered virus,
its late-season introduction could be evidence of an intentional
effort to panic human populations.
If designed,
it was intended to spread, not kill. It lacks the PB1-F2 marker
for pathogenicity (tissue damage) seen in the dreaded but poorly
transmitted H5N1 bird flu virus that drew concern in 2003.3
Yet, in vulnerable individuals, those with pre-existing disease
or smokers or pregnant females, there is a greater (though still
small) risk of death.
Wishy-washy
origins
Researchers
attempt to explain that this unique flu virus "was derived
from several viruses circulating in swine, and that initial transmission
to humans occurred several months before recognition of the outbreak."
Without evidence in hand, the world community of virologists concluded
that this virus "emerged from a triple reassortant virus
circulating in North American swine." Yet no mass culling
of herds of swine was called for.6
The swine origin
of this flu is nonsense since no swine herds exhibited this virus
till detection months following the initial flu outbreak in Mexico,
suggesting it was transmitted from humans to pigs, not the other
way around. Using pigs as a cover for the true origin of the disease
also suggests a broad cover-up within the community of microbiologists
and public health authorities.
For factual
documentation, the first detection by the US Department of Agriculture
of H1N1 pandemic influenza in pigs in the US occurred between August
26 and September 1 at the Minnesota State Fair, almost 6 months
after the first case in Mexico.4
However, this
fact was not revealed till months later, claimed to be an effort
to protect US pig farmers when their business had already been destroyed
by association of this flu virus with flu strains commonly found
in swine herds.5
Researchers
go on to say, in a confusing and inexplicable fashion, that "a
phylogenetic estimate of the gaps in genetic surveillance indicates
a long period of unsampled ancestry before the swine-flu outbreak,
suggesting that the reassortment of swine lineages may have occurred
years before emergence in humans, and that the multiple genetic
ancestry of this swine flu is not indicative of an artificial origin."6
Here is intentional
wording to dismiss any thought of an engineered virus. Yet the authors
of this report are suggesting the many flu-monitoring stations across
the globe completely missed detection of this virus as it mutated
and re-assorted into its current form. Yet there has been no call
to check for flaws in classifying viral strains which would have
obviously occurred.
These researchers
go on to say, that without samples of its ancestors, the immediate
origin of this flu strain is difficult to determine. The closest
relatives to this flu strain existed between 9.2 and 17.2 years
ago, "depending upon the genetic segment" analyzed.
Investigators claim it must have been circulating in pigs "for
several years" before emergence in humans.6
Its Asian-origin
flu strain segments lead researchers to blame the movement of pigs
between Eurasia and North America for its unique viral re-assortment.
Yet shipment of swine herds is one way, from North America to Asia,
and there are quarantine periods so that new arrivals don’t infect
an existing herd. Influenza lasts only a few days and quarantine
methods would eliminate any transfer to another herd. Unlike humans,
pigs produce their own vitamin C and swine herd flu outbreaks are
typically mild and not mortal.
Warning
of influenza as a bioweapon
In 2003
researchers at the Center for Biosecurity and Public Health,
University of Texas–Houston Health Center, Houston, Texas, warned
that influenza could be made into a bioweapon to produce disease
and death of major proportion. Unlike other biological threats like
anthrax, influenza only requires 3 to 6 airborne viral particles,
27,000 times fewer viral particles than obtained by direct contact
(hands) to produce infection. In 14 days, its incubation period,
it can start replicating and producing symptoms of diarrhea, vomiting
and coughing serious enough for hospitalization and use of a respirator.
Its victims often succumb to a sudden mortal heart attack, which
does not directly end up on statistical health summaries as flu-related
death.7
Once a flu
pandemic has begun it is difficult to halt because immunization
after exposure to the flu is not protective, and anti-flu drugs
(Tamiflu, Relenza) must be administered before symptoms develop
or within the first 48 hours after their appearance. Early on, flu
symptoms may appear similar to other biological threats like anthrax,
so it is difficult to ascertain that a human population is under
an intentional biological attack.8
Flu viruses
evolve to protect humanity?
Jeffery K.
Taubenberger, M.D., Ph.D. Senior Investigator in National Institute
of Allergy & Infectious Diseases, and Anthony S. Fauci, M.D.,
Director of that Institute, say theH1N1 pandemic flu
is afourth-generation descendantof the 1918
virus.
This virus
caused an explosiveand historic pandemic, during which
humans also transmittedthe virus to pigs, they concede.
Taubenberger and Fauci take evolutionary theory to the height of
its absurdity by stating:
"… successive
pandemics and pandemic-likeevents generally appear
to be decreasing in severity over time.This diminution
… may reflect viral evolutionary‘choices’ that favor
optimal transmissibility with minimal pathogenicity
a virus that kills its hosts or sends them to bed isnot optimally transmissible."
Huh? We’ve
heard of "survival of the fittest," and "natural
selection" (where heritable traits make it more likely
an organism will survive and successfully reproduce itself), but
here we have a new and novel definition of evolution – the flu virus
genome is selecting against its own survival in preference to survival
of humans!8
How a tailored
flu virus would be produced
In 2003 Robert
M. Krug, writing in the journal Antiviral Research, wrote a landmark
report entitled "The potential use of influenza virus as
an agent for bioterrorism." Krug said:
"If
such a lethal human influenza A virus does not emerge in nature,
it is likely that it can be generated in the laboratory, utilizing
the recently developed reverse genetic system, whereby influenza
viruses can be generated by transfection (a process of introducing
nucleic acids into cells) of multiple DNAs."15
This can be
accomplished by transiently opening pores or holes in the cell membrane
to allow entrance of viral particles. In fact, the deadly H5N1 bird
flu virus (kills 6 in 10 infected humans) has already been generated
in at least one laboratory at the University of Wisconsin using
this reverse genetic system.9
This topic
was covered in my LRC article entitled "The Deadliest Flu
Virus In The World."10
Krug writes:
"There
is every reason to believe that the same recombinant DNA techniques
can be used to render this H5N1 virus transmissible from humans
to humans. Furthermore, it should be possible to introduce mutations
into such a recombinant virus so that it is resistant to currently
available influenza virus antivirals (M2 inhibitors: amantadine
and rimantadine; and NA inhibitors: zanamivir and oseltamivir-Tamiflu
and Relenza), and so that it is unlike…. recently circulating
human viruses. In fact, several viruses (at one time) … could
be generated. The human population would lack immunological protection
against such viruses, existing antiviral drugs would not afford
any protection, and these viruses could be spread simply by release
of an aerosol spray in several crowded areas."15
In this instance,
if the current H1N1 pandemic flu virus was engineered, it was designed
to be vulnerable to Tamiflu and Relenza, but not amantadine and
rimantadine. With the current delay in delivery of the vaccine,
one wonders if this whole pandemic hasn’t been engineered to deplete
aging stocks of Tamiflu that nations have been piling up in anticipation
of "the big one" – the supposed long-overdue "great
flu pandemic."
The question
is, could there be some villainous bioterrorist in some foreign
country who has the capability of covertly starting a flu virus
in a remote village in Mexico, and only infect one child there,
and then see it spread around the world? If so, this flu pandemic
actually petered out by July of 2009, as CBS News uncovered, but
re-emerged in the following months as the dominant strain of flu
virus in circulation.11
Pandemic
flu strains predominates
Was this pandemic
strain of the flu re-introduced or re-engineered at that time, to
make it more prevalent?
The current
strain of the flu in circulation as of the first week in November
2009 is 99% H1N1 pandemic strain. The seasonal flu strains have
vanished. There is no need to undergo vaccination for seasonal flu.
Health authorities knew some time ago that the H1N1 pandemic flu
strain overwhelms seasonal flu strains. The exact date of that discovery
is unclear because we only have the date of publication of that
discovery. The first evidence for this was produced some time earlier.12
Whether a biological
terrorist re-introduced the H1N1 strain into North American human
populations after it was fizzling out in July is certainly speculation,
but is a question that needs asking.
Laboratory
origin: no amateur bioterrorists
Krug goes on
to say:
"It
can be argued that most terrorists would not have the knowledge,
facilities and ingenuity to carry out these recombinant DNA experiments.
This is probably the case at the present time, but the situation
can be expected to change in the future, perhaps after as little
as 5–10 years."15
Currently there
is no revealed intelligence that there is a nefarious bioterrorist
at large developing pandemic flu viruses. If the current pandemic
flu strain in circulation was designed in a laboratory, it would
likely be a university or military lab, just as the origin of anthrax
was traced back to the Army lab at Fort Detrick in Maryland.13
We should also
not forget that the news media repeatedly attempted to distract
the public as to the real origins of the anthrax, falsely suggesting
the bentonite additive found in the anthrax samples, spread in the
ventilation ducts at offices of US Congressmen in Washington DC,
originated in Iraq, the only country known to use that additive.
A false connection was being made between the anthrax and Iraqi
leader Saddam Hussein by ABC chief investigative correspondent Brian
Ross on October 26, 2001, shortly following the attacks on the World
Trade Center in New York.14 So the
public should be wary of the news media that may be complicit with
other sources to create politically-correct conclusions as to the
origin of the H1N1 swine flu.
Vaccination
strategy is inherently flawed
Krug goes on
to say:
"Vaccination
will probably be of limited value against an influenza virus bioterrorist
attack. Currently it takes about 6 months to prepare a vaccine
against a new influenza virus strain. Perhaps reverse genetic
approaches can shorten this time somewhat, but there will still
be a few months between an influenza virus outbreak and the availability
of a protective vaccine. In addition, the vaccine approach can
be readily thwarted by bioterrorists who could spread several
influenza viruses with different HA antigenic sites."15
So the current
effort to control influenza, largely being centered on vaccination,
is flawed and should be curtailed. Of course, that is not what is
being played out in the currently unfolding vaccine drama
Only antivirals
are left in defense
Krug then says:
"In contrast, antiviral drugs that are directed at functions
shared
by all influenza A virus strains constitute the best line of defense
against a bioterrorist attack. Currently the NA (neuraminidase)
inhibitors (zanamivir and oseltamivir-Tamiflu and Relenza) are the
only such antivirals available."15
Stockpiles
of anti-viral drugs, which now proliferate across the globe, could
become useless due to limited shelf life. So far, manufacturers
have been testing and extending the shelf life of their anti-viral
products. The World Health Organization holds 2 million treatment
courses of Tamiflu and another 3 million courses are held in stock
by Roche as part of their rapid response stockpile.16
Anti-virals
are somewhat effective in prophylaxis of the flu, but over-use of
these anti-viral drugs induces viral resistance.17
It is interesting
to note that 99.6% of the 2008 seasonal flu strains were resistant
to Tamiflu.18 To move Tamiflu off
of shelves, the seasonal flu had to vanish, which is exactly what
has occurred. This suggests aerosol flu viruses are being seeded
into the population to create designed flu pandemics.
As mentioned
earlier in this report, the H1N1 pandemic flu now in circulation
has virtually overtaken all other flu strains, as if by design,
in an apparent attempt to deplete the millions of doses of Tamiflu
whose shelf life expires in 20092010. The US has a stockpile
of over 50 million doses to clear off its shelves that outdates
soon.19
Vaccine
makers, government, presage the pandemic
For unexplained
reasons, in 2008 the manufacturer of Tamiflu in Japan projected
a 531% increase in sales in 2009, as if presaging the flu pandemic
now underway.20
Has this whole
flu escapade, its late-season onset, the otherwise inexplicable
delays in delivery of the vaccine, been staged to dump millions
of nearly-outdated Tamiflu pills on the world masses who have been
whipped up into flu hysteria?
On June 27,
2008, nearly 8 months prior to the first reports of the H1N1 pandemic
flu emanating out of Mexico, the maker of Tamiflu began urging companies
to buy stockpiles of their product, a sales effort that was endorsed
by the Department of Health & Human Services. This suggests
massive collusion between the makers of anti-viral drugs and public
health authorities in staging this pandemic.
On June 27,
2008, a deputy secretary for the Department of Health & Human
Services is quoted as saying: "I think the (Tamiflu) program
is unprecedented in that we are facing an unprecedented threat."21
Exactly which unprecedented flu threat was this government employee
talking about at the time?
References:
- Cello J,
Paul AV, Wimmer E, Chemical
Synthesis of Poliovirus cDNA: Generation of Infectious Virus in
the Absence of Natural Template Science 297, 1016 (2002).
- Neumann
G, Kawaoka Y, Synthesis
of influenza virus: new impetus from an old enzyme, RNA polymerase
I. Virus Research. 2002 Jan 30; 82(12):1538.
- Wang TT,
Palese P, Unraveling
the Mystery of Swine Influenza Virus Cell
137, June 12, 2009.
- Petrosillo
N, Di Bella S, Drapeau CM, Grilli E, The
novel influenza A (H1N1) virus pandemic: An update. Annals
Thoracic Medicine. 2009 Oct;4(4):16372.
- United
States USDA take 3 months to disclose swine flu.
Meat Trade News Daily Nov. 4, 2009.
- Smith GJD,
Vijakrishna D, Bahl J, et al, Origins and evolutionary genomics
of the 2009 swine-origin H1N1 influenza A epidemic. Nature Volume
459, 25 June 2009. http://www.ncbi.nlm.nih.gov/pubmed/11885943
- Madjid
M, Lillibridge S, Mirhaji P, Casscells W, Influenza
as a bioweapon. Journal Royal Society Medicine 2003 96 (7);
34546.
- Morens
DM, Taubenberger JK, Fauci AS, The Persistent Legacy of the 1918
Influenza Virus. New England Journal Medicine 361(3): 22529,
July 16, 2009.
- Hatta M,
Gao P, Halfmann P, Kawaoka Y, Molecular
basis for high virulence of Hong Kong H5N1 influenza A viruses.
Science 2001 Sep 7; 293(5536):18402.
- The
Deadliest Flu Virus in the World: Made in USA.
- Atkinson
S, Swine
flu cases overestimated? CBS News Oct. 21, 2009.
- Perez,
D., Sorrell, E., Angel, M., Ye, J., Hickman, D., Pena, L., Ramirez-Nieto,
G., Kimble, B., & Araya, Y. August 25, 2009. Fitness
of Pandemic H1N1 and Seasonal influenza A viruses during Co-infection
PLoS Currents RRN1011.2.
- Anthrax
attack bug "identical" to army strain." New Scientist.
May 9, 2002.
- Troubling
Anthrax Additive Found, Brian Ross, Christopher Isham, Chris
Vlasto and Gary Matsumoto, ABC.com, October 26, 2001
- Krug RM,
The potential use of influenza virus as an agent for bioterrorism.
Antiviral Research 57 (2003) 147–150.
- Roche
deploys rapid response stockpile of Tamiflu Reuters Sat May
2, 2009.
- Eichner
M, Schwehm M, Duerr HP, et al, Antiviral prophylaxis during pandemic
influenza may increase drug resistance. BMC Infectious Diseases
2009; 9: 233439.
- "20082009
Influenza Season Week ending September 5, 2009 "CDC,
Sep. 18, 2009.
- Stockpiled
Antivirals at or Nearing Expiration. US Food & Drug Administration.
- Chugai
Pharmaceutical, Annual Report 2008.
- Mary Brophy
Marcus, U.S.
firms can stockpile Tamiflu. USA TODAY June 27, 2008.
November
9, 2009
Bill
Sardi [send
him mail] is a frequent writer on health and political
topics. His health writings can be found at www.naturalhealthlibrarian.com.
He is the author of You
Don’t Have To Be Afraid Of Cancer Anymore.
Copyright
© 2009 Bill Sardi Word of Knowledge Agency, San Dimas, California.
This article has been written exclusively for www.LewRockwell.com
and other parties who wish to refer to it should link rather than
post at other URLs.
The
Best of Bill Sardi
|